ProShare Advisors LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q4 2019$236,000
+8.3%
7,077
+16.6%
0.00%0.0%
Q2 2019$218,000
-15.2%
6,068
-12.8%
0.00%
-50.0%
Q1 2019$257,000
+13.7%
6,955
+32.6%
0.00%0.0%
Q4 2018$226,0005,2450.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders